Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001537286-26-000002
Filing Date
2026-04-28
Accepted
2026-04-28 18:17:13
Documents
2
Period of Report
2026-04-24

Document Format Files

Seq Description Document Type Size
1 form4-04282026_100406.html 4  
1 form4-04282026_100406.xml 4 3695
2 ex24-04282026_100407.htm EX-24 4060
  Complete submission text file 0001537286-26-000002.txt   9137
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400
Business Address
Blount Sally E. (Reporting) CIK: 0001537286 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-02189 | Film No.: 26909688